-

04:22:30 PM

TFX Stock News

TFX - Teleflex Incorporated

06/16/21 6:30 AM

NYSE : TFX

New Data Suggest Men with Urinary Symptoms Often Anticipate Bathroom Needs and Avoid Events and Activities They Enjoy

Teleflex Incorporated (NYSE: TFX) today announced results of a new survey showing that men with urinary

RHEA-AI

neutral

06/07/21 6:30 AM

NYSE : TFX

conferences

Teleflex to Present at the Raymond James 2021 Human Health Innovation Conference

Thomas Powell, Executive Vice President and Chief Financial Officer, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Raymond James 2021 Human Health Innovation Conference on Monday, June 21, 2021 at 8:40 a.m. (ET). A live audio webcast

RHEA-AI

neutral

05/18/21 6:30 AM

NYSE : TFX

Teleflex Signs Definitive Agreement to Sell Certain Respiratory Assets and Reaffirms Adjusted EPS Guidance

Total consideration is $286 million, reduced by $12 million of working capital to be retained by Teleflex Assets to be divested generated $139M in 2020 revenue, with 2021 growth expected to be approximately flat 2021 headwinds are estimated at $28-32 million in revenue and $0.10-$0.15 in adjusted

RHEA-AI

neutral

05/11/21 6:30 AM

NYSE : TFX

conferences

Teleflex to Present at the UBS Global Healthcare Virtual Conference

May 11, 2021 – Thomas Powell, Executive Vice President and CFO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the UBS Global Healthcare Virtual Conference on Tuesday, May 25, 2021 at 3:00 p.m. (ET). A live audio webcast of the conference

RHEA-AI

neutral

05/03/21 6:30 AM

NYSE : TFX

dividends

Teleflex Announces Quarterly Dividend

Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable June 15, 2021 to shareholders of record at the close of

RHEA-AI

neutral

04/29/21 6:30 AM

NYSE : TFX

Teleflex Reports First Quarter 2021 Results

First quarter 2021 revenues of $633.9 million, up 0.5% versus prior year period on an as-reported basis; down 2.6% on a constant currency basis First quarter 2021 GAAP diluted EPS from continuing operations of $1.58, compared to $2.78 in the prior year period First quarter 2021 adjusted diluted EPS

RHEA-AI

negative

04/27/21 6:30 AM

NYSE : TFX

conferences

Teleflex to Present at the Bank of America Securities 2021 Virtual Health Care Conference

Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Bank of America Securities 2021 Virtual Health Care Conference on Tuesday, May 11, 2021 at 8:00 a.m. (ET). A live audio webcast of the conference

RHEA-AI

neutral

04/15/21 6:30 AM

NYSE : TFX

earnings

Teleflex Announces First Quarter 2021 Earnings Conference Call Information

Teleflex Incorporated (NYSE: TFX) announced today that financial results for the first quarter 2021 will be released before market open on Thursday, April 29, 2021. An investor

RHEA-AI

neutral

03/10/21 6:30 AM

NYSE : TFX

conferences

Teleflex to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

Jake Elguicze, Treasurer and Vice President of Investor Relations, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on Wednesday, March 24, 2021 at 9:15am (ET). A live

RHEA-AI

neutral

03/09/21 6:30 AM

NYSE : TFX

Teleflex Reports 250,000 Patients Treated for Enlarged Prostate With the Minimally Invasive UroLift® System

Teleflex Incorporated (NYSE: TFX) today announced that, globally, 250,000 patients have been treated with the UroLift ® System, a proven, minimally invasive approach to treating benign prostatic hyperplasia (BPH). In the United States alone, more

RHEA-AI

neutral

Prev 1 2 3 4 5 6 7 8 9 10 Next

TFX Data

IndustrySurgical and Medical Instrument Manufacturing
Websitewww.teleflex.com
Security nameTeleflex Incorporated
Issue typecs
SectorManufacturing
Sic code3841
Employees14000
Tags
- Health Technology
- Medical Specialties
- Manufacturing
- Surgical and Medical Instrument Manufacturing
Address550 E Swedesford Rd Ste 400
StatePennsylvania
CityWayne
Zip19087-1601
CountryUS
Phone16102256800

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. The Company applys purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Its portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia, emergency medicine, surgical, urology and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference.